beta-Blocker and renal function.

Hyperinsulinemic Euglycemia and Intravenous Lipid Emulsion Treatments for Calcium Channel Blocker and Beta Blocker Poisoning: A Report of Two Cases

Poisoning with calcium channel blockers and beta blockers are associated with high mortality and morbidity rates, especially in children. Treatment of poisoning with these drugs includes administration of atropine, glucagon, calcium and inotropic agents as clinically needed; and newer approaches like hyperinsulinemic euglycemia and intravenous lipid emulsion therapies. We herein present two ref...

Calcium channel blocker and renal mitochondrial function in warm renal ischemia.

OBJECTIVE Ions, particularly calcium ions, play an important role in ischemia-reperfusion cell injury. In this study, we investigated the action of verapamil on the mitochondrial function of kidneys submitted to ischemia without blood reperfusion in order to study isolated early and late ischemic effects. MATERIALS AND METHODS 44 rats were submitted to bilateral warm renal ischemia for 30 min...

Nonselective (Propranolol) Beta-adrenergic Blocker

delayed repolarization syndromes. Mod Concepts Cardiovasc Dis 45: 117, 1976 28. Castellanos A, Salhanick L: Electrocardiographic patterns of procainamide cardiotoxicity. Am J Med Sci 253: 52, 1967 29. Epstein MA: Ventricular standstill during the intravenous procainamide treatment of ventricular tachycardia. Am Heart J 45: 890, 1953 30. Seiklos P, Chalme TM, Evans DW: Ventricular tachycardia af...

Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor.

The effects of a nonselective beta-adrenergic blocking drug with beta-2 agonist activity (dilevalol 200 mg) on proteinuria and renal hemodynamics were evaluated in a double-blind crossover study versus an ACE inhibitor (enalapril 5 mg) in eight patients with glomerulonephritis, moderate renal function impairment and proteinuria greater than 1 g/24 hr. Patients were studied after a one week plac...

A young renal transplant recipient with unexplained resting sinus tachycardia, hypertension and beta-blocker resistance.